Debt is not a concern for Aurobindo Pharma as it evaluates potential large acquisitions, including Prague-based Zentiva, said ...

According to ICRA, rising financial literacy, consistent equity returns, and digital platforms have made SIPs the most ...

The Centre introduced landmark bills in Lok Sabha to remove Prime Ministers, Chief Ministers and Ministers detained for 30 ...

The Light Combat Aircraft Mark1A is an upgraded version of the Tejas fighter jet, which is developed by HAL. It is built to ...

K Natarajan, MD & CEO of Galaxy Surfactants, said Europe and Latin America delivered strong performance, while Africa and the Middle East remained flat due to past supply challenges, which are now ...

As of June 30, Clean Sciences' promoters held 74.97% stake in the company. Ashok Boob held 12.8% stake, while Krishna Boob held 2.6% stake in individual capacity. Meanwhile, Krishnakumar Ramnarayan ...

The fund will be managed by Karthik Kumar and Hitesh Das, and aims to provide investors with low-cost and transparent exposure to 50 high-quality companies selected from the Nifty 500 universe.

Aurobindo Pharma's shares fell 4% on Wednesday after reports indicated that the company is set to acquire Zentiva at a price between $5 billion to $5.5 billion.